Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system
about
Genome-wide association study identifies single nucleotide polymorphism in DYRK1A associated with replication of HIV-1 in monocyte-derived macrophagesEffects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy eraChronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistenceRedefining the viral reservoirs that prevent HIV-1 eradicationHIV-associated neuropathogenesis: a systems biology perspective for modeling and therapyGenetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorderRational development of radiopharmaceuticals for HIV-1Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disordersPharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of AntiretroviralsGuidelines for Evaluation and Management of Cognitive Disorders in HIV-Positive IndividualsTargeting the Brain Reservoirs: Toward an HIV CureEfavirenz and the CNS: what we already know and questions that need to be answeredCompartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementiaLong-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimensThe NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytesNeurocognitive impairment in patients treated with protease inhibitor monotherapy or triple drug antiretroviral therapyComputational modeling reveals distinct effects of HIV and history of drug use on decision-making processes in womenEfficient Inhibition of HIV Replication in the Gastrointestinal and Female Reproductive Tracts of Humanized BLT Mice by EFdASystems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's diseaseHIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment.Barriers to HIV Cure.Clinical Trials in Neurovirology: Successes, Challenges, and PitfallsHIV and antiretroviral therapy: impact on the central nervous system.Antiretroviral therapy: Shifting sandsNeurotoxic effects of AZT on developing and adult neurogenesisA novel computerized functional assessment for human immunodeficiency virus-associated neurocognitive disorder.Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infection.Progressive multifocal leukoencephalopathy in HIV-1 infection.Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDSVisual function assessment in simulated real-life situations in HIV-infected subjects.Neurologic presentations of AIDS.Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individualsCombination antiretroviral therapy modulates the blood oxygen level-dependent amplitude in human immunodeficiency virus-seropositive patients.Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents.Mode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid isolates.Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART.Diffuse White Matter Signal Abnormalities on Magnetic Resonance Imaging Are Associated With Human Immunodeficiency Virus Type 1 Viral Escape in the Central Nervous System Among Patients With Neurological SymptomsHIV-1 neuroimmunity in the era of antiretroviral therapy.Time-Dependent, HIV-Tat-Induced Perturbation of Human Neurons In Vitro: Towards a Model for the Molecular Pathology of HIV-Associated Neurocognitive DisordersNeurocognitive function in HIV-positive children in a developing country.
P2860
Q21135536-B6D00B22-5BDA-4B2B-B46C-D524F77E6320Q24632654-D91BC023-1A3E-45BF-ACCE-BF60A87BF515Q26825762-95D89BB5-057A-4865-9B36-9C6572D7CAC7Q26827255-622961D2-4BAA-47F0-83E0-7DCD25D12471Q26859071-848ADF0A-34EC-4581-B100-27795A4C6BB9Q26865707-D9BFD025-E569-4AE7-994D-61FF58A3C565Q27022025-8AEEBCA7-6165-4289-A94D-C93EB4B1A9C3Q27025573-DE4A5F04-236A-466F-8BD6-FDB98272047BQ28069383-EB1E31D6-017E-4FBA-9013-A6F047BA0E4BQ28073408-0CD04F9E-6254-4734-BA4B-8CC7FDCECE68Q28075694-94C97960-F428-404C-9140-1DAA10671319Q28085028-19B93E53-417D-4624-AFBB-B02C305FD200Q28475360-52B1528F-514E-46F6-94FA-8156C3986B49Q28485321-3F6A8367-D132-4145-B1CC-9DD5B0FBB728Q28486204-BA5749C6-58E0-40F6-A442-03BE9B7D848EQ28534903-66E37710-AF6C-40CB-A837-EFC6CF5FCB13Q28535185-11AF7B36-E3F2-4B51-8A81-B9AA520D765DQ28552730-8AB04761-CE77-490E-80B9-AFA90FD1BF7BQ28709047-BCF96238-EC8B-402F-9EF2-9ED58984DAC3Q30234305-B67F71BB-3020-4982-BC8B-A66E9DB8B21EQ30245414-1BEED9D0-3ED5-4EA9-8FF2-60BF94B30F84Q30250271-41210A53-A3ED-4A75-BAE5-A026661A3D2CQ30381932-3736A8ED-3E99-4066-BEA4-8FBF20238A5FQ30384683-8E6A629B-548F-4281-A5D0-DF02C0EE5634Q30414740-1459C09B-2BBA-4BF6-9037-3129D1CCCCECQ30548228-6DDD4F70-04D7-4865-80EB-10E24ABA1AA8Q30690955-C3197425-B8D7-48E9-8FC9-DAB823597D1BQ33506561-2BBC8D3B-899B-4041-8285-CEC3D54742D5Q33580220-2D52DA49-A374-4553-868B-887F19B245BAQ33584301-413172F1-AB99-464B-88F2-EDD9C294B146Q33590337-BB3FD117-FE03-4796-8BEA-214F08CF1A61Q33614467-199CBA1B-B261-4995-8F4F-918FE862C967Q33640874-64D8354F-3702-4EB4-86ED-9A9BE03EEE0DQ33650149-15A1648E-8720-464D-B2B7-81AD6EE1D202Q33686847-EA41C648-84A9-4969-9C5A-434BFF61CCCAQ33699222-36EB0AE5-F09C-421B-B1C3-A306B9FEFFC4Q33712027-62237919-4D7A-403A-8843-65379FA74D87Q33733529-276A14E3-D875-44F9-8E87-A08CE64F8E6EQ33734695-75AB8B70-4252-4417-9B64-C9B839C67A93Q33754219-7A0E807E-AA80-44F6-9D2B-90F4F94AAD71
P2860
Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Validation of the CNS Penetrat ...... nto the central nervous system
@en
Validation of the CNS Penetrat ...... to the central nervous system.
@nl
type
label
Validation of the CNS Penetrat ...... nto the central nervous system
@en
Validation of the CNS Penetrat ...... to the central nervous system.
@nl
prefLabel
Validation of the CNS Penetrat ...... nto the central nervous system
@en
Validation of the CNS Penetrat ...... to the central nervous system.
@nl
P2093
P2860
P50
P1433
P1476
Validation of the CNS Penetrat ...... nto the central nervous system
@en
P2093
Ann C Collier
Benjamin B Gelman
Brookie Best
David Clifford
David Simpson
Edmund Capparelli
J Allen McCutchan
Jennifer Marquie-Beck
Justin C McArthur
P2860
P356
10.1001/ARCHNEUROL.2007.31
P577
2008-01-01T00:00:00Z